Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07594886 · ClinicalTrials.gov registry record
Left Atrial Pressure-Guided Heart Failure Optimization During Atrial Fibrillation Ablation (LAP AF-HF)
A clinical trial, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- 300
- Enrollment target
NCT07594886 is a clinical trial that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 300 participants.
The verdict
NCT07594886 is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
Study Summary
This study examines whether measuring blood pressure inside the left upper chamber of the heart during a procedure to treat an irregular heartbeat called atrial fibrillation can help identify patients who would benefit from heart failure medications. During atrial fibrillation ablation, a catheter crosses into the left atrium, allowing direct measurement of left atrial pressure. When the pressure is elevated (15 mmHg or higher), it may indicate that the heart is under strain from unrecognized or undertreated heart failure. Patients with elevated left atrial pressure during ablation are referred for heart failure evaluation and medication optimization within 24 hours of the procedure. The study compares outcomes in these patients to a group of patients who had the same elevated pressures but received standard care without a structured heart failure evaluation. The study measures whether the heart failure treatment pathway leads to greater use of recommended heart failure medications, improvements in heart pumping function and heart chamber size, and reduction in irregular heartbeat episodes over the following year
Interventions
- BEHAVIORAL LAP-Triggered Heart Failure Optimization Pathway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2029-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07594886
The ClinicalTrials.gov registry entry for NCT07594886 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LAP-Triggered Heart Failure Optimization Pathway is the first listed.
NCT07594886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07594886 about?
NCT07594886 is a clinical study titled "Left Atrial Pressure-Guided Heart Failure Optimization During Atrial Fibrillation Ablation (LAP AF-HF)". This study examines whether measuring blood pressure inside the left upper chamber of the heart during a procedure to treat an irregular heartbeat called atrial fibrillation can help identify patients who would benefit from heart failure medications. During atrial fibrillation ablation, a catheter c...
What is the current status of trial NCT07594886?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2024-02-12. Estimated completion is 2029-12-31.
What interventions are being tested in trial NCT07594886?
The interventions under investigation include: LAP-Triggered Heart Failure Optimization Pathway (BEHAVIORAL).
Who is sponsoring clinical trial NCT07594886?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.